HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,915.00
+60.00 (1.56%)
At close: Dec 5, 2025

HLB Life Science Revenue

HLB Life Science had revenue of 13.60B KRW in the quarter ending September 30, 2025, with 65.94% growth. This brings the company's revenue in the last twelve months to 114.33B, up 147.10% year-over-year. In the year 2024, HLB Life Science had annual revenue of 102.24B with 4.34% growth.

Revenue (ttm)
114.33B
Revenue Growth
+147.10%
P/S Ratio
4.17
Revenue / Employee
747.24M
Employees
153
Market Cap
477.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024102.24B4.25B4.34%
Dec 31, 202397.99B-1.60B-1.61%
Dec 31, 202299.59B46.10B86.17%
Dec 31, 202153.49B-38.30B-41.73%
Dec 31, 202091.80B-22.22B-19.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Korea Electric Power 97.28T
Korea Gas 36.71T
Korea District Heating 4,036.41B
SK eternix 357.16B
Samchully Co.,Ltd 5,246.34B
Korea Electric Power Industrial Development 383.07B
INVENI 1,309.10B
Seoul City Gas 1,819.62B
Revenue Rankings